Non-thrombotic ischemic cerebrovascular events related to the use of tyrosine kinase inhibitors in patients with cancer: high-resolution magnetic resonance imaging findings
The targeted cancer therapies that have been introduced in recent years are directed against cancer-specific molecules and signaling pathways, and thus, they have limited nonspecific toxicities. However, major vascular events, including stroke, are common in patients receiving tyrosine kinase inhibi...
Main Authors: | Jae Eun Sim, Jeongho Park, Oh Young Bang |
---|---|
Format: | Article |
Language: | English |
Published: |
Sungkyunkwan University School of Medi
2021-12-01
|
Series: | Precision and Future Medicine |
Subjects: | |
Online Access: | http://www.pfmjournal.org/upload/pdf/pfm-2021-00072.pdf |
Similar Items
-
Spleen tyrosine kinase (SYK) signals are implicated in cardio-cerebrovascular diseases
by: Mohan Li, et al.
Published: (2023-05-01) -
Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma
by: Emmy D. G. Fleuren, et al.
Published: (2023-03-01) -
Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
by: Domenico Ribatti
Published: (2010-04-01) -
Novel Tyrosine Kinase Targets in Urothelial Carcinoma
by: Javier Torres-Jiménez, et al.
Published: (2021-01-01) -
Tyrosine Kinase Receptors in Oncology
by: Jorge Esteban-Villarrubia, et al.
Published: (2020-11-01)